Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2019 June;61(2) > Panminerva Medica 2019 June;61(2):138-51

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

 

REVIEW  HOT TOPICS IN MALE INFERTILITY 

Panminerva Medica 2019 June;61(2):138-51

DOI: 10.23736/S0031-0808.18.03512-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Paternal age and assisted reproductive technology: problem solver or trouble maker?

Mariana BERTONCELLI TANAKA 1, Ashok AGARWAL 2, Sandro C. ESTEVES 1, 3, 4

1 Division of Urology, Department of Surgery, University of Campinas (UNICAMP), Campinas, Brazil; 2 American Center for Reproductive Medicine, Department of Urology, Cleveland Clinic, Cleveland, OH, USA, 3 Andrology and Human Reproduction Clinic ANDROFERT, Campinas, Brazil; 4 Faculty of Health, Aarhus University, Aarhus, Denmark



In our society, the number of couples with advanced reproductive age seeking fertility treatment is increasing steadily. While the negative effect of female age on assisted reproductive technology (ART) outcomes is well established, the impact of paternal age needs to be clarified. We reviewed the current literature to determine whether advanced paternal age affects the results of ART and the health of resulting offspring. We found that the published literature is overall supportive of a positive association between advanced paternal age (>40 years) and semen quality deterioration. However, the existing evidence does not corroborate nor discard the influence of advanced paternal age on ART outcomes. Similarly, the effect of paternal age on the health of ART offspring remains equivocal, although data from naturally-conceived children clearly indicates that advanced paternal age increases the frequency of genetic, neurodevelopmental, and psychiatric diseases in the progeny. Noteworthy, the current literature is limited and subjected to bias due to the impact of maternal age as a critical confounder. Health care providers should discuss with concerned couples the available options to counteract the possible negative influence of advanced paternal age on ART outcomes and health of resulting offspring. These include identification and treatment of underlying conditions with potential negative long-term effects on fertility, sperm freezing at a young age, and use of antioxidant supplements for men at risk of excessive oxidative stress. Aged male partner from couples undergoing ART, in particular men of 50 years and older, should consider use of preimplantation genetic testing as a means to detect embryo abnormalities and select euploid embryos for transfer to the uterine cavity.


KEY WORDS: Paternal age - Reproductive techniques, assisted - Fertilization in vitro - Sperm injections, intracytoplasmic - Infertility, male

inizio pagina